Amerigen Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Amerigen Pharmaceuticals Ltd (Amerigen Pharmaceuticals) is a pharmaceutical product manufacturer that develops, markets pharmaceutical products. The companys portfolio consists of products under development that are filed or anticipated to be filed as abbreviated new drug application with the Chinese CFDA and the US FDA. It focuses on developing orally delivered products with specific technology and complex regulatory and intellectual property issues. Amerigen Pharmaceuticals develops drugs in collaboration with various pharmaceutical companies. The company operates through its subsidiaries in Lyndhurst, New Jersey, the US and Suzhou, Jiangsu Province and China, among others. Amerigen Pharmaceuticals is headquartered in Lyndhurst, New Jersey, the US.

Amerigen Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Amerigen Pharma and Biophore India Pharma Enter into Agreement 10
Amerigen Pharma Enters into Co-Development Agreement with Ningbo Menovo Pharma 11
Amerigen Pharma Enters Into Co-Development Agreement With Forest Labs For Specialty Generic Products 12
Amerigen Pharma Enters Into Co-Development Agreement With Shanghai Fosun Omni Pharma 13
Amerigen Pharma And VIWA Pharma Enter Into JV To Develop And Sell Generics In China 14
Equity Offering 15
Amerigen Pharma to Raise USD35 Million in Private Placement of Shares 15
Amerigen Pharma Raises USD35 Million in Private Placement of Shares 16
Amerigen Pharmaceuticals Ltd - Key Competitors 17
Amerigen Pharmaceuticals Ltd - Key Employees 18
Amerigen Pharmaceuticals Ltd - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables


Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amerigen Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Amerigen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Amerigen Pharma and Biophore India Pharma Enter into Agreement 10
Amerigen Pharma Enters into Co-Development Agreement with Ningbo Menovo Pharma 11
Amerigen Pharma Enters Into Co-Development Agreement With Forest Labs For Specialty Generic Products 12
Amerigen Pharma Enters Into Co-Development Agreement With Shanghai Fosun Omni Pharma 13
Amerigen Pharma And VIWA Pharma Enter Into JV To Develop And Sell Generics In China 14
Amerigen Pharma to Raise USD35 Million in Private Placement of Shares 15
Amerigen Pharma Raises USD35 Million in Private Placement of Shares 16
Amerigen Pharmaceuticals Ltd, Key Competitors 17
Amerigen Pharmaceuticals Ltd, Key Employees 18
Amerigen Pharmaceuticals Ltd, Subsidiaries 19

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Amerigen Pharmaceuticals Ltd - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Amerigen Pharmaceuticals Ltd (Amerigen Pharmaceuticals) is a pharmaceutical product manufacturer that develops, markets pharmaceutical products. The companys portfolio consists of products under development that are filed or anticipated to be

USD 250 View Report

Amerigen Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Amerigen Pharmaceuticals Ltd (Amerigen Pharmaceuticals) manufactures, develops and markets generic pharmaceutical products. The companys portfolio consists of products under development that are filed or anticipated to be filed as

USD 250 View Report

NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review

NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Paradigm Biopharmaceuticals Ltd (PAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Paradigm Biopharmaceuticals Ltd (Paradigm Biopharma) is a biopharmaceutical company. The company focused on research and development of therapeutic products for human use. It offers pentosan polysulphate sodium (PPS) drugs for

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available